Bate joins Archemix from NitroMed where he served as President and CEO.Previously, Mr. Bate held positions as Executive Vice President, Head ofCommercial Operations and Chief Financial Officer of Millennium Pharmaceuticalsand as Vice President of Sales and Marketing and Chief Financial Officer atBiogen (now Biogen Idec). He is a founding partner of JSB Partners, aninvestment banking and transaction advisory firm focused on thebiopharmaceutical industry. Currently a director of Cubist Pharmaceuticals, Inc.and AVEO Pharmaceuticals Inc., Mr. Bate is a graduate of Williams College andThe Wharton School of the University of Pennsylvania, where he earned an M.B.A.
About AptamersAptamers are synthetically-derived oligonucleotides, or short nucleic acidsequences, that bind to protein targets with high affinity and specificity andcan be designed to have a specified duration of action. Aptamers represent anemerging class of potential therapeutic agents that Archemix believes may havebroad application to treat a variety of human diseases. About ArchemixArchemix is a biotechnology company focused on discovering, developing andcommercializing aptamer therapeutics. Using Archemix`s processes for discoveringaptamers, which are protected by its broad patent portfolio, Archemix isdeveloping aptamer product candidates for rare hematological diseases.
Inaddition, Archemix has licensed its intellectual property to third parties todevelop their own aptamer product candidates in other areas. Currently,Archemix`s licensees are evaluating five different aptamer product candidates inhuman clinical trials; two in Phase 2 and three in Phase 1. Archemix hasadditional partnerships with several pharmaceutical and biotechnology companies,including GlaxoSmithKline, Merck Serono, Pfizer, Takeda, Eli Lilly and IsisPharmaceuticals. Yates Public RelationsBarbara Yates, 781-258-6153orKathryn Morris, 845-635-9828 Copyright Business Wire 2009. PARIS & AMSTERDAM--(Business Wire)--Orange Business Services and Canon Europe have reached an agreement on athree-year contract for the processing of incoming telephone traffic at Canon`sEuropean contact centers. The contract covers the telephone calls from Canon`scustomers in 19 European countries to three contact centers. Canon has decided to use Orange Business Services due to the speed of theexecution, the competitive pricing and the strong performance in projectmanagement.
Service & ServicesCalls from customers about products and services are processed at the Canoncontact centers. Customers are automatically and seamlessly connected with oneof the three contact centers in Europe when they call one of the 57 availablelocal helpdesk numbers where they are assisted by specially trainedprofessionals. The calls are routed through technologies such as PSTN (PublicSwitched Telephone Network), Shared Cost and UIFN (Universal InternationalFreephone Number), that ensure efficient call processing with a fast start-up About CanonCanon Europe is a subsidiary of Canon Inc. of Japan, a world-leading innovatorand provider of imaging solutions for individuals and businesses. The main business focus for Canon Europe is in two clearly defined markets:Business Solutions (developing IT products, solutions and services for theoffice and professional print environments) and Consumer Imaging (photo, video,printers, scanners, fax machines and multifunction devices).